NSD2 Inhibitors Reprogram Chromatin to Fight Cancer
In the relentless quest to conquer some of the deadliest cancers, researchers have illuminated a novel therapeutic vulnerability nestled deep ...
In the relentless quest to conquer some of the deadliest cancers, researchers have illuminated a novel therapeutic vulnerability nestled deep ...
In the complex landscape of cancer treatment, the persistent challenge of chemo-resistance continues to limit the efficacy of chemotherapy agents, ...
A groundbreaking beacon in pancreatic cancer research is shining brighter with the emergence of glutamic-oxaloacetic transaminase 2 (GOT2) as a ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine